Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first…

Hims & Hers’ new alternative to Novo Nordisk’s Wegovy pill will sell for $49 for the first month and $99…

Novo Nordisk said on Thursday it would take legal action against Hims & Hers after the online telehealth company said…

The compounded pill is less expensive than the oral version of Wegovy, which costs $149 to get started.…

Hims & Hers has a GLP-1 weight loss pill -- and its the cheapest one out there.…

US telehealth group will sell product for $49 a month, a third that of its Danish competitor…

Hims & Hers Health shares are trading higher Thursday after the company launched a compounded copy of the Wegovy pill…

Hims & Hers said it would begin offering compounded versions of Novo Nordisks Wegovy pill at an introductory price of…

Hims & Hers Health launched a knockoff version of Novo Nordisks already popular weight-loss pill on Thursday.…

Hims Hers (HIMS) confirmed that starting today, eligible customers can access treatment plans that include compounded semaglutide pills at…

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisks (NVO) Wegovy…

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

SAN FRANCISCO, February 05, 2026--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform,…

Hims & Hers (NYSE:HIMS) has announced the launch of a compounded semaglutide pill designed for weight loss, providing an alternative…

Competition has already arrived for Novo Nordisks Wegovy pill, as telehealth company Hims & Hers launches a compounded version…

Hims Hers Health, Inc. (“Hims Hers”, NYSE: HIMS), the leading health and wellness platform, today announced an expansion…

At Hims & Hers, we believe the best outcomes start with choice. That’s why across every speciality, we’ve always prioritized…

Grail has teamed up with telehealth company Hims & Hers to boost access to its recently filed Galleri blood test…

We came across a?bullish thesis?on Hims & Hers Health, Inc. on Investment Edge’s Substack by David Vicuña. In this article, we…

New insider activity at Hims & Hers Health ( ($HIMS) ) has taken place on February 4, 2026. Hims &…

If you are wondering whether Hims & Hers Health at US$25.54 still offers value after its big run in recent…

If you are wondering whether Hims & Hers Health at around US$25.54 is starting to look interesting or stretched, you…

Hims & Hers (NYSE: HIMS) announced today the launch of an early detection cancer test, bringing more value to its…

Hims & Hers is moving beyond prescriptions to preventative testing.…

Telehealth company Hims & Hers has added Grail’s blood cancer test Galleri to its offerings as the medtech continues to…

Hims & Hers Health shares are trending Wednesday after the company announced it launched access to the Hims & Hers…

Hims & Hers Health said Wednesday it launched a multi-cancer early detection blood test that can identify signals for…

Key Takeaways: Hims & Hers Health (HIMS) introduces the Galleri multi-cancer early detection test, offering a $250…

Hims & Hers launches multi-cancer blood test screening for 50+ cancers…

Hims & Hers (HIMS) stock gains as the company company launches Galleri multi-cancer early detection test developed by GRAIL (GRAL).…

The company will offer access to Galleri ® , an innovative blood test from GRAIL, Inc. that screens for more…